2 completed, 2 terminated, 1 active not recruiting. 5 Phase 2, 1 Phase 3.
By phase and status
Follow venglustat: new trials by email Literature Review of venglustat trials Research Report on venglustat
Trials (filtered) newest first · largest first
All 5 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix .
Trial Phase Status Sponsor Enrollment Start Updated
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients Venglustat, Placebo - Polycystic Kidney, Autosomal Dominant Phase 2 / Phase 3 Terminated 478 2018-10-04 2023-02-03
Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extension venglustat (GZ402671), imiglucerase - Gaucher Disease Type 1, Gaucher Disease Type 3 Phase 2 Active not recruiting 12 2017-01-04 2026-07-10
A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation venglustat GZ/SAR402671, Placebo - Parkinson's Disease Phase 2 Terminated 273 2016-12-15 2022-05-24
Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease GZ/SAR402671 - Fabry Disease Phase 2 Completed 8 2015-07-07 2021-03-23
Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease GZ/SAR402671 - Fabry Disease Phase 2 Completed 11 2014-11-01 2019-12-17
Conditions studied Fabry Disease (2) · Gaucher Disease (1) · Parkinson Disease (1) · Polycystic Kidney, Autosomal Dominant (1)
Sponsors Genzyme, a Sanofi Company (5)
Countries United Kingdom (5) · United States (5) · France (4) · Germany (3) · Japan (3) · Poland (3) · Austria (2) · Canada (2) · Israel (2) · Italy (2) · Portugal (2) · Russia (2) · Spain (2) · Taiwan (2) · Argentina (1)
Results publications PMID 36481125 , PMID 34897099 , PMID 36204243 , PMID 36535535 , PMID 37050861 , PMID 37479372 , PMID 38802634 , PMID 39356039
NIH funding 2014 (2) , 2016 (1) , 2017 (1) , 2023 (1)